KRAS and Combined KRAS/TP53 Mutations in Locally Advanced Rectal Cancer are Independently Associated with Decreased Response to Neoadjuvant Therapy
Crossref DOI link: https://doi.org/10.1245/s10434-016-5205-4
Published Online: 2016-03-28
Published Print: 2016-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chow, Oliver S.
Kuk, Deborah
Keskin, Metin
Smith, J. Joshua
Camacho, Niedzica
Pelossof, Raphael
Chen, Chin-Tung
Chen, Zhenbin
Avila, Karin
Weiser, Martin R.
Berger, Michael F.
Patil, Sujata
Bergsland, Emily
Garcia-Aguilar, Julio
Text and Data Mining valid from 2016-03-28